Do analysts rate OGI or ACB?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Organigram Global 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Aurora Cannabis 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts prefer CGC or OGI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Canopy Growth 1 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.17 Organigram Global 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33

Do analysts recommend CRON or OGI?

Cronos Group currently has a consensus price target of $2.30, indicating a potential downside of 14.81%. Given Cronos Group's higher probable upside, analysts plainly believe Cronos Group is more favorable than Organigram Global. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cronos Group 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20 Organigram Global 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33

Do analysts recommend OGI or SNDL?

SNDL has a consensus price target of $5.00, indicating a potential upside of 249.65%. Given SNDL's higher possible upside, analysts plainly believe SNDL is more favorable than Organigram Global. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Organigram Global 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 SNDL 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has higher valuation and earnings, OGI or SNDL?

SNDL has higher revenue and earnings than Organigram Global. SNDL is trading at a lower price-to-earnings ratio than Organigram Global, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Organigram Global $185.07M 0.72 -$17.70M -$0.13 N/A SNDL $937.39M 0.39 -$11.29M -$0.03 N/A

Is OGI or SNDL more profitable?

SNDL has a net margin of -1.19% compared to Organigram Global's net margin of -9.22%. SNDL's return on equity of -1.02% beat Organigram Global's return on equity. Company Net Margins Return on Equity Return on Assets Organigram Global -9.22% -13.41% -9.09% SNDL -1.19% -1.02% -0.85%

Do analysts recommend TLRY or OGI?

Tilray Brands currently has a consensus price target of $11.50, suggesting a potential upside of 149.46%. Given Tilray Brands' higher possible upside, analysts clearly believe Tilray Brands is more favorable than Organigram Global. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tilray Brands 1 Sell rating(s) 4 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.25 Organigram Global 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33

Organigram Global (OGI) Competitors

$0.95 -0.01 (-0.94%)

Closing price 04:00 PM Eastern

Extended Trading

$0.97 +0.02 (+1.58%)

As of 07:48 PM Eastern

Compare

OGI vs. ACB, CGC, CRON, SNDL, and TLRY

Should you buy Organigram Global stock or one of its competitors? MarketBeat compares Organigram Global with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Organigram Global include Aurora Cannabis (ACB), Canopy Growth (CGC), Cronos Group (CRON), SNDL (SNDL), and Tilray Brands (TLRY). These companies are all part of the "pharmaceutical products" industry.

How does Organigram Global compare to Aurora Cannabis?

Organigram Global (NASDAQ:OGI) and Aurora Cannabis (NASDAQ:ACB) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, valuation, profitability, risk, institutional ownership, analyst recommendations, earnings and dividends.

Organigram Global has a net margin of -9.22% compared to Aurora Cannabis' net margin of -33.57%. Aurora Cannabis' return on equity of 0.10% beat Organigram Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Organigram Global	-9.22%	-13.41%	-9.09%
Aurora Cannabis	-33.57%	0.10%	0.07%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Organigram Global	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Aurora Cannabis	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Organigram Global's average media sentiment score of 0.00 equaled Aurora Cannabis'average media sentiment score.

Company	Overall Sentiment
Organigram Global	Neutral
Aurora Cannabis	Neutral

Organigram Global has a beta of 1.43, indicating that its stock price is 43% more volatile than the broader market. Comparatively, Aurora Cannabis has a beta of 0.53, indicating that its stock price is 47% less volatile than the broader market.

34.6% of Organigram Global shares are owned by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are owned by institutional investors. 0.1% of Organigram Global shares are owned by insiders. Comparatively, 0.0% of Aurora Cannabis shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Organigram Global has higher earnings, but lower revenue than Aurora Cannabis. Organigram Global is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Organigram Global	$185.07M	0.72	-$17.70M	-$0.13	N/A
Aurora Cannabis	$247.82M	0.71	-$88.13M	-$1.56	N/A

Summary

Organigram Global beats Aurora Cannabis on 8 of the 13 factors compared between the two stocks.

How does Organigram Global compare to Canopy Growth?

Canopy Growth (NASDAQ:CGC) and Organigram Global (NASDAQ:OGI) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, media sentiment, earnings, institutional ownership, risk, analyst recommendations and valuation.

In the previous week, Canopy Growth had 9 more articles in the media than Organigram Global. MarketBeat recorded 9 mentions for Canopy Growth and 0 mentions for Organigram Global. Canopy Growth's average media sentiment score of 0.12 beat Organigram Global's score of 0.00 indicating that Canopy Growth is being referred to more favorably in the media.

Company	Overall Sentiment
Canopy Growth	Neutral
Organigram Global	Neutral

3.3% of Canopy Growth shares are held by institutional investors. Comparatively, 34.6% of Organigram Global shares are held by institutional investors. 0.2% of Canopy Growth shares are held by insiders. Comparatively, 0.1% of Organigram Global shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Organigram Global has lower revenue, but higher earnings than Canopy Growth. Organigram Global is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Canopy Growth	$251.01M	1.52	-$190.29M	-$0.59	N/A
Organigram Global	$185.07M	0.72	-$17.70M	-$0.13	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Canopy Growth	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17
Organigram Global	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Canopy Growth has a beta of 0.77, meaning that its stock price is 23% less volatile than the broader market. Comparatively, Organigram Global has a beta of 1.43, meaning that its stock price is 43% more volatile than the broader market.

Organigram Global has a net margin of -9.22% compared to Canopy Growth's net margin of -75.27%. Organigram Global's return on equity of -13.41% beat Canopy Growth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Canopy Growth	-75.27%	-26.95%	-17.20%
Organigram Global	-9.22%	-13.41%	-9.09%

Summary

Organigram Global beats Canopy Growth on 8 of the 14 factors compared between the two stocks.

How does Organigram Global compare to Cronos Group?

Cronos Group (NASDAQ:CRON) and Organigram Global (NASDAQ:OGI) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, earnings, risk, analyst recommendations and media sentiment.

Cronos Group has a beta of 0.89, suggesting that its stock price is 11% less volatile than the broader market. Comparatively, Organigram Global has a beta of 1.43, suggesting that its stock price is 43% more volatile than the broader market.

Cronos Group has higher earnings, but lower revenue than Organigram Global. Organigram Global is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cronos Group	$146.59M	6.87	-$9.45M	$0.01	270.00
Organigram Global	$185.07M	0.72	-$17.70M	-$0.13	N/A

8.7% of Cronos Group shares are held by institutional investors. Comparatively, 34.6% of Organigram Global shares are held by institutional investors. 7.8% of Cronos Group shares are held by company insiders. Comparatively, 0.1% of Organigram Global shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Cronos Group currently has a consensus price target of $2.30, indicating a potential downside of 14.81%. Given Cronos Group's higher probable upside, analysts plainly believe Cronos Group is more favorable than Organigram Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cronos Group	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20
Organigram Global	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Cronos Group has a net margin of -1.14% compared to Organigram Global's net margin of -9.22%. Cronos Group's return on equity of -1.26% beat Organigram Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cronos Group	-1.14%	-1.26%	-1.20%
Organigram Global	-9.22%	-13.41%	-9.09%

In the previous week, Cronos Group had 3 more articles in the media than Organigram Global. MarketBeat recorded 3 mentions for Cronos Group and 0 mentions for Organigram Global. Cronos Group's average media sentiment score of 0.71 beat Organigram Global's score of 0.00 indicating that Cronos Group is being referred to more favorably in the media.

Company	Overall Sentiment
Cronos Group	Positive
Organigram Global	Neutral

Summary

Cronos Group beats Organigram Global on 11 of the 15 factors compared between the two stocks.

How does Organigram Global compare to SNDL?

Organigram Global (NASDAQ:OGI) and SNDL (NASDAQ:SNDL) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, profitability, risk, valuation, earnings, analyst recommendations and media sentiment.

Organigram Global has a beta of 1.43, meaning that its share price is 43% more volatile than the broader market. Comparatively, SNDL has a beta of 0.91, meaning that its share price is 9% less volatile than the broader market.

SNDL has higher revenue and earnings than Organigram Global. SNDL is trading at a lower price-to-earnings ratio than Organigram Global, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Organigram Global	$185.07M	0.72	-$17.70M	-$0.13	N/A
SNDL	$937.39M	0.39	-$11.29M	-$0.03	N/A

In the previous week, SNDL had 1 more articles in the media than Organigram Global. MarketBeat recorded 1 mentions for SNDL and 0 mentions for Organigram Global. Organigram Global's average media sentiment score of 0.00 equaled SNDL'saverage media sentiment score.

Company	Overall Sentiment
Organigram Global	Neutral
SNDL	Neutral

SNDL has a net margin of -1.19% compared to Organigram Global's net margin of -9.22%. SNDL's return on equity of -1.02% beat Organigram Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Organigram Global	-9.22%	-13.41%	-9.09%
SNDL	-1.19%	-1.02%	-0.85%

34.6% of Organigram Global shares are owned by institutional investors. 0.1% of Organigram Global shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

SNDL has a consensus price target of $5.00, indicating a potential upside of 249.65%. Given SNDL's higher possible upside, analysts plainly believe SNDL is more favorable than Organigram Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Organigram Global	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
SNDL	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

SNDL beats Organigram Global on 8 of the 15 factors compared between the two stocks.

How does Organigram Global compare to Tilray Brands?

Tilray Brands (NASDAQ:TLRY) and Organigram Global (NASDAQ:OGI) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, analyst recommendations, media sentiment, dividends, earnings and risk.

9.4% of Tilray Brands shares are owned by institutional investors. Comparatively, 34.6% of Organigram Global shares are owned by institutional investors. 0.8% of Tilray Brands shares are owned by insiders. Comparatively, 0.1% of Organigram Global shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Organigram Global has lower revenue, but higher earnings than Tilray Brands. Organigram Global is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tilray Brands	$821.31M	0.65	-$2.19B	-$13.65	N/A
Organigram Global	$185.07M	0.72	-$17.70M	-$0.13	N/A

Tilray Brands currently has a consensus price target of $11.50, suggesting a potential upside of 149.46%. Given Tilray Brands' higher possible upside, analysts clearly believe Tilray Brands is more favorable than Organigram Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tilray Brands	1 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.25
Organigram Global	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Tilray Brands has a beta of 1.88, indicating that its share price is 88% more volatile than the broader market. Comparatively, Organigram Global has a beta of 1.43, indicating that its share price is 43% more volatile than the broader market.

In the previous week, Tilray Brands had 21 more articles in the media than Organigram Global. MarketBeat recorded 21 mentions for Tilray Brands and 0 mentions for Organigram Global. Tilray Brands' average media sentiment score of 0.64 beat Organigram Global's score of 0.00 indicating that Tilray Brands is being referred to more favorably in the media.

Company	Overall Sentiment
Tilray Brands	Positive
Organigram Global	Neutral

Organigram Global has a net margin of -9.22% compared to Tilray Brands' net margin of -156.51%. Tilray Brands' return on equity of -3.31% beat Organigram Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tilray Brands	-156.51%	-3.31%	-2.42%
Organigram Global	-9.22%	-13.41%	-9.09%

Summary

Tilray Brands beats Organigram Global on 10 of the 16 factors compared between the two stocks.

Get Organigram Global News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OGI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

OGI vs. The Competition

Export

Metric	Organigram Global	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$135.14M	$8.08B	$6.45B	$12.39B
Dividend Yield	N/A	2.60%	2.69%	5.83%
P/E Ratio	-7.32	15.24	24.92	23.98
Price / Sales	0.72	6.98	529.01	109.54
Price / Cash	N/A	16.83	44.82	54.51
Price / Book	0.51	3.21	10.79	6.50
Net Income	-$17.70M	$226.25M	$3.56B	$336.88M
7 Day Performance	-5.84%	-3.57%	1.67%	-0.22%
1 Month Performance	-15.09%	-3.72%	0.43%	0.77%
1 Year Performance	-25.70%	1.93%	32.84%	31.57%

Organigram Global Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
OGI Organigram Global	0.5361 of 5 stars	$0.95 -0.9%	N/A	-25.6%	$135.14M	$185.07M	N/A	1,139
ACB Aurora Cannabis	0.3321 of 5 stars	$3.01 +2.0%	N/A	-29.7%	$184.63M	$247.82M	N/A	1,130
CGC Canopy Growth	1.4915 of 5 stars	$0.96 -2.8%	N/A	-22.8%	$386.22M	$225.65M	N/A	3,150	Trending News Insider Trade
CRON Cronos Group	1.5352 of 5 stars	$2.61 -0.8%	$2.30 -11.9%	+42.5%	$973.61M	$146.59M	261.26	450	News Coverage
SNDL SNDL	3.4634 of 5 stars	$1.44 +0.3%	$5.00 +248.4%	+12.0%	$369.37M	$677.32M	N/A	2,751	High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:OGI) was last updated on 6/23/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Organigram Global (OGI) Competitors

OGI vs. ACB, CGC, CRON, SNDL, and TLRY

How does Organigram Global compare to Aurora Cannabis?

Summary

How does Organigram Global compare to Canopy Growth?

Summary

How does Organigram Global compare to Cronos Group?

Summary

How does Organigram Global compare to SNDL?

Summary

How does Organigram Global compare to Tilray Brands?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OGI vs. The Competition

Organigram Global Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Organigram Global (OGI) Competitors

OGI vs. ACB, CGC, CRON, SNDL, and TLRY

How does Organigram Global compare to Aurora Cannabis?

Is OGI or ACB more profitable?

Do analysts rate OGI or ACB?

Does the media prefer OGI or ACB?

Which has more risk & volatility, OGI or ACB?

Do institutionals and insiders hold more shares of OGI or ACB?

Which has stronger earnings and valuation, OGI or ACB?

Summary

How does Organigram Global compare to Canopy Growth?

Does the media favor CGC or OGI?

Do institutionals & insiders hold more shares of CGC or OGI?

Which has higher valuation & earnings, CGC or OGI?

Do analysts prefer CGC or OGI?

Which has more volatility and risk, CGC or OGI?

Is CGC or OGI more profitable?

Summary

How does Organigram Global compare to Cronos Group?

Which has more risk and volatility, CRON or OGI?

Which has stronger valuation & earnings, CRON or OGI?

Do insiders & institutionals believe in CRON or OGI?

Do analysts recommend CRON or OGI?

Is CRON or OGI more profitable?

Does the media favor CRON or OGI?

Summary

How does Organigram Global compare to SNDL?

Which has more volatility & risk, OGI or SNDL?

Which has higher valuation and earnings, OGI or SNDL?

Does the media refer more to OGI or SNDL?

Is OGI or SNDL more profitable?

Do institutionals & insiders believe in OGI or SNDL?

Do analysts recommend OGI or SNDL?

Summary

How does Organigram Global compare to Tilray Brands?

Do institutionals and insiders hold more shares of TLRY or OGI?

Which has higher earnings & valuation, TLRY or OGI?

Do analysts recommend TLRY or OGI?

Which has more risk and volatility, TLRY or OGI?

Does the media favor TLRY or OGI?

Is TLRY or OGI more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OGI vs. The Competition

Organigram Global Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools